1. Home
  2. PESI vs ACIU Comparison

PESI vs ACIU Comparison

Compare PESI & ACIU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Perma-Fix Environmental Services Inc.

PESI

Perma-Fix Environmental Services Inc.

HOLD

Current Price

$12.19

Market Cap

243.9M

Sector

Industrials

ML Signal

HOLD

Logo AC Immune SA

ACIU

AC Immune SA

HOLD

Current Price

$3.34

Market Cap

213.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PESI
ACIU
Founded
1990
2003
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Environmental Services
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
243.9M
213.3M
IPO Year
1996
2015

Fundamental Metrics

Financial Performance
Metric
PESI
ACIU
Price
$12.19
$3.34
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$10.00
AVG Volume (30 Days)
195.7K
244.5K
Earning Date
05-07-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
43.61
N/A
EPS
N/A
N/A
Revenue
$642,000.00
N/A
Revenue This Year
$34.62
$635.38
Revenue Next Year
$77.02
$232.58
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.07
$1.45
52 Week High
$16.50
$4.00

Technical Indicators

Market Signals
Indicator
PESI
ACIU
Relative Strength Index (RSI) 50.19 61.19
Support Level $11.01 $3.18
Resistance Level $12.37 $3.43
Average True Range (ATR) 0.71 0.20
MACD 0.20 0.07
Stochastic Oscillator 86.11 81.91

Price Performance

Historical Comparison
PESI
ACIU

About PESI Perma-Fix Environmental Services Inc.

Perma-Fix Environmental Services Inc is a provider of both nuclear services and the management of nuclear and mixed waste. The company operates through two segments: The treatment segment offers nuclear, low-level radioactive, Mixed, hazardous and non-hazardous waste treatment, processing and disposal services, and the Services segment which generates the majority of the revenue, provides on-site waste management services to commercial and government customers, technology-based services, construction, logistics, and transportation services among others.

About ACIU AC Immune SA

AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses mostly of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.

Share on Social Networks: